A Olivi1, H Brem. Show Affiliations » 1. Department of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, MD 21205.
Abstract
Entities: Disease
Mesh： See more » AnimalsAntineoplastic Agents/administration & dosageAntineoplastic Agents/adverse effectsAntineoplastic Agents/therapeutic useBiocompatible MaterialsBrain Neoplasms/drug therapyBrain Neoplasms/surgeryCarmustine/administration & dosageCarmustine/adverse effectsCarmustine/therapeutic useCarmustine/toxicityChemotherapy, AdjuvantClinical Trials, Phase II as TopicClinical Trials, Phase III as TopicCombined Modality TherapyDecanoic AcidsDelayed-Action PreparationsDouble-Blind MethodDrug CarriersDrug ImplantsDrug Screening Assays, AntitumorGlioblastoma/drug therapyGlioblastoma/mortalityGlioblastoma/surgeryGlioma/drug therapyGlioma/surgeryHumansNeoplasm Recurrence, Local/drug therapyPolyestersProspective StudiesRandomized Controlled Trials as TopicRatsSalvage TherapySurvival Analysis
Substances： See more » Antineoplastic AgentsBiocompatible MaterialsDecanoic AcidsDelayed-Action PreparationsDrug CarriersDrug ImplantsPolyestersdecanedioic acid-4,4'-(1,3-propanediylbis(oxy))bis(benzoic acid) copolymerCarmustine
Year: 1994 PMID： 8047689 DOI： 10.1007/978-3-642-85039-4_15
Source DB: PubMed Journal: Recent Results Cancer Res ISSN： 0080-0015